Isolated aortic root dilation in homocystinuria
- PMID: 28980096
- PMCID: PMC5786652
- DOI: 10.1007/s10545-017-0094-7
Isolated aortic root dilation in homocystinuria
Abstract
Background: Vascular complications in homocystinuria have been known for many years, but there have been no reports to date on involvement of the ascending aorta.
Methods: We conducted a cross-sectional study of patients with homocystinuria, known to a single metabolic centre, and evaluated in 2016 with a transthoracic echocardiogram. Aortic root dilation was defined as Z-score ≥ 2.0 SD, and graded mild (Z-score 2.0-3.0), moderate (Z-score 3.01-4.0) and severe (Z-score > 4.0).
Results: The study population included 34 patients, median age of 44.3 years (IQR 33.3-52.2), 50% males, 69% diagnosed aged <18 years and 29% pyridoxine-responsive. Eight (24%) had a history of hypertension. Seven patients (21%) were found to have a dilation of the aortic root, mild in two cases (6%), moderate in four (12%) and severe in one (3%). None had dilation of the ascending aorta. Significant aortic regurgitation, secondary to moderate aortic root dilation, was documented in two patients. A single patient had significant mitral regurgitation due to prolapse of both valve leaflets, as well as mild aortic root dilation. Comparing patients with a dilation of the aortic root to those without, there were no significant clinical, laboratory or echocardiographic differences, with the only exception being that the diameter of the ascending aorta was larger in the group with a dilated aortic root, albeit within normal limits.
Conclusions: A subset of patients with homocystinuria have isolated dilation of the aortic root similar to that observed in Marfan syndrome.
Conflict of interest statement
Elaine Murphy and Robin Lachmann have received honoraria and project grant funding from Nutricia. Massimiliano Lorenzini, Nishan Guha, James Davidson, Alex Pitcher, Bejal Pandya, Helena Kemp and Perry Elliott declare that they have no conflict of interest.
Figures

References
-
- Braverman AC, Harris KM, Kovacs RJ, Maron BJ (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 7: aortic diseases, including Marfan syndrome. Circulation 132:e303–e309 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical